| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
University of Texas System Cancer Center, Science Park, Research Division, Smithville, Texas 78957 [D. C. H., K. D. M.], and Department of Medical and Physiological Chemistry, University of Uppsala, The Biomedical Center, Uppsala, Sweden [B. Ö.]
Alterations in the expression of normal cell surface components on 13 transplantable hepatocellular carcinomas were examined using a heteroantiserum [anti-Mr 105,000 glycoprotein (gp105)] reactive with a family of nine wheat germ agglutinin binding components from normal rat hepatocytes with an average molecular weight of 105,000. Analysis by two-dimensional polyacrylamide gel electrophoresis of components immunoprecipitated by anti-gp105 antiserum from detergent extracts of transplantable hepatocellular carcinoma cells surface labeled with 125I revealed qualitative and quantitative changes in the expression of anti-gp105-reactive components with the most consistent change being the apparent loss of a pair of acidic (pl 4.1 to 4.3) glycoproteins by all 13 transplantable hepatocellular carcinoma lines. One-dimensional peptide maps of fragments produced following digestion with V8 protease indicated that these acidic components were closely related in structure but differed significantly from other anti-gp105-reactive components. Immunodepletion analysis with monoclonal antibodies and heteroantisera reactive with individual components recognized by anti-gp105 antiserum showed that the two acidic glycoproteins were antigenically and structurally identical to cell-CAM 105, a Mr 105,000 glycoprotein involved in cell-cell adhesion of rat hepatocytes. Antibodies raised against purified cell-CAM 105 were specific in immunoprecipitation assays for the acidic components, strongly inhibited reaggregation of hepatocytes, and displayed no reactivity by indirect immunofluorescence or immunoprecipitation analysis with transplantable hepatocellular carcinoma cells. These results suggest that major alterations in the expression of cell-CAM 105 may be a consistent feature of the malignant phenotype.
1 This research was supported by Grant CA 31103 from the NIH, the Swedish Medical Research Council (Project 05200, 6686), and Konung Gustaf Vis 80-arsfond.
2 To whom requests for reprints should be addressed.
Received 12/10/84. Revised 3/26/85. Accepted 4/ 3/85.
This article has been cited by other articles:
![]() |
N. Kilic, L. Oliveira-Ferrer, S. Neshat-Vahid, S. Irmak, K. Obst-Pernberg, J.-H. Wurmbach, S. Loges, E. Kilic, J. Weil, H. Lauke, et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1 Blood, December 15, 2007; 110(13): 4223 - 4233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Edwards and M. A. Apicella The Molecular Mechanisms Used by Neisseria gonorrhoeae To Initiate Infection Differ between Men and Women Clin. Microbiol. Rev., October 1, 2004; 17(4): 965 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Phan, C.-J. Cheng, M. Galfione, F. Vakar-Lopez, J. Tunstead, N. E. Thompson, R. R. Burgess, S. M. Najjar, L.-Y. Yu-Lee, and S.-H. Lin Identification of Sp2 as a Transcriptional Repressor of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Tumorigenesis Cancer Res., May 1, 2004; 64(9): 3072 - 3078. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Volpert, W. Luo, T.-J. Liu, V. T. Estrera, C. Logothetis, and S.-H. Lin Inhibition of Prostate Tumor Angiogenesis by the Tumor Suppressor CEACAM1 J. Biol. Chem., September 13, 2002; 277(38): 35696 - 35702. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brummer, A. Ebrahimnejad, R. Flayeh, U. Schumacher, T. Loning, A.-M. Bamberger, and C. Wagener cis Interaction of the Cell Adhesion Molecule CEACAM1 with Integrin {beta}3 Am. J. Pathol., August 1, 2001; 159(2): 537 - 546. [Abstract] [Full Text] |
||||
![]() |
P. Soni, M. Lakkis, M. N. Poy, M. A. Fernström, and S. M. Najjar The Differential Effects of pp120 (Ceacam 1) on the Mitogenic Action of Insulin and Insulin-Like Growth Factor 1 Are Regulated by the Nonconserved Tyrosine 1316 in the Insulin Receptor Mol. Cell. Biol., June 1, 2000; 20(11): 3896 - 3905. [Abstract] [Full Text] |
||||
![]() |
B. B. Singer, I. Scheffrahn, and B. Öbrink The Tumor Growth-inhibiting Cell Adhesion Molecule CEACAM1 (C-CAM) Is Differently Expressed in Proliferating and Quiescent Epithelial Cells and Regulates Cell Proliferation Cancer Res., March 1, 2000; 60(5): 1236 - 1244. [Abstract] [Full Text] |
||||
![]() |
W. A. Campbell, D. E. Sah, M. M. Medina, J. E. Albina, W. B. Coleman, and N. L. Thompson TA1/LAT-1/CD98 Light Chain and System L Activity, but Not 4F2/CD98 Heavy Chain, Respond to Arginine Availability in Rat Hepatic Cells. LOSS OF RESPONSE IN TUMOR CELLS J. Biol. Chem., February 25, 2000; 275(8): 5347 - 5354. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sadekova, N. Lamarche-Vane, X. Li, and N. Beauchemin The CEACAM1-L Glycoprotein Associates with the Actin Cytoskeleton and Localizes to Cell-Cell Contact through Activation of Rho-like GTPases Mol. Biol. Cell, January 1, 2000; 11(1): 65 - 77. [Abstract] [Full Text] |
||||
![]() |
L. Riethdorf, B. W. Lisboa, U. Henkel, M. Naumann, C. Wagener, and T. Loning Differential Expression of CD66a (BGP), a Cell Adhesion Molecule of the Carcinoembryonic Antigen Family, in Benign, Premalignant, and Malignant Lesions of the Human Mammary Gland J. Histochem. Cytochem., July 1, 1997; 45(7): 957 - 964. [Abstract] [Full Text] |
||||
![]() |
J. S. Reichner, J. A. Mulligan, M. E. Palla, D. C. Hixson, J. E. Albina, and K. I. Bland Interleukin-6 Production by Rat Hepatocellular Carcinoma Cells Is Associated With Metastatic Potential but Not With Tumorigenicity Arch Surg, April 1, 1996; 131(4): 360 - 365. [Abstract] [PDF] |
||||
![]() |
I Hunter, M Lindh, and B Obrink Differential regulation of C-CAM isoforms in epithelial cells J. Cell Sci., January 5, 1994; 107(5): 1205 - 1216. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |